Drugs
- NMPA issues the Announcement on Adjusting the Relevant Matters Concerning the Definition of the Attributes of Drug/Device Combination Products
- CDE releases the List of the Second Batch of Overseas New Drugs Urgently Needed in Clinical Settings
- NMPA issues the Announcement on Issues Concerning the Import of Reference Drugs for Clinical Research of Biosimilar Drugs
- SAMR issues the Measures for the Administration of Imported Medicinal Materials
Medical Devices
- Rules for Classification of Medical Devices
- Provisions for Instructions and Labels of Medical Devices (Decree No.6 of China Food and Drug Administration)
- NMPA issues the Guiding Principles for Capacity Building of Medical Device Inspection and Testing Organizations
- NMPA issues the Rules for Unique Identification System for Medical Devices
Vaccination
- ICMRA publishes statements about confidence in vaccine safety and effectiveness
- China starts latest trial of long-lasting HIV vaccine
- NMPA issues notice on publicity and implementation of Vaccine Administration Law
- Why is vaccination important for addressing antibiotic resistance?
- Questions and answers on immunization and vaccine safety
Cosmetics
- NMPA issues the Announcement on Implementing Work Specifications for Cosmetics Registration and Recordfiling Inspection
- NMPA issues the Guiding Principles for Capacity Building of Cosmetics Inspection and Testing Institutions
- Cosmetics Safety Q&A: eye cosmetic safety
- Cosmetics Safety Q&A: shelf life
- News
- Dupixent receives green light to treat asthma from Chinese National Medical Products Administration
- Fruquintinib becomes first made-in-Shanghai drug to be prescribed overseas
- China boasts over 10,000 major pharmaceutical industrial firms
- China announces new round of centralized procurement for medical consumables
